Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
338 studies found for:    nasopharyngeal cancer | "Nasopharyngeal Neoplasms"
Show Display Options
Rank Status Study
21 Not yet recruiting Measuring Patient-Reported Adverse Events in Oncology Practice Improves Quality of Life in Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Neoplasms
Interventions: Other: adverse events using patient-reported outcomes version of common terminology criteria for adverse events (PRO-CTCAE) questionaire;   Other: do not report adverse events through patient-reported outcomes version of common terminology criteria for adverse events (PRO-CTCAE) questionaire
22 Completed The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT
Condition: Nasopharyngeal Neoplasms
Interventions: Drug: Cisplatin;   Drug: Paclitaxel;   Radiation: IMRT
23 Unknown  Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Neoplasms
Intervention: Drug: Oxaliplatin
24 Not yet recruiting Efficacy and Safety of FORRAD® for the Management of Radiation-induced Mucositis in Patients With Nasopharyngeal Carcinoma Receiving IMRT
Conditions: Nasopharyngeal Neoplasms;   Stomatitis
Interventions: Drug: Oral Ulcer Gargle (FORRAD®);   Drug: Quadruple mixture, composed of dexamethasone, gentamicin, vitamin B12, and procaine
25 Not yet recruiting Comparison of Efficacy and Safety Between Medical Radiation Protectants (FORRAD®) and Trolamine (Biafine) for the Management of Radiation Dermatitis in Patients With Nasopharyngeal Carcinoma Receiving IMRT
Conditions: Nasopharyngeal Neoplasms;   Radiodermatitis
Interventions: Drug: Medical Radiation Protectants (FORRAD®);   Drug: Trolamine (Biafine)
26 Recruiting Predictive Factors of Acute Oral Mucositis Induced by Chemo-radiotherapy for Local Advanced Nasopharyngeal Carcinoma
Conditions: Nasopharyngeal Neoplasms;   Stomatitis
Intervention:
27 Completed The Value of Diagnosis and Outcome Prediction in CTC for Metastatic NPC Patients
Condition: Nasopharyngeal Neoplasms
Intervention: Other: the number of circulating tumor cells
28 Completed Environmental and Genetic Determinants of NPC
Conditions: Nasopharyngeal Neoplasms;   Herpesvirus 4, Human
Intervention:
29 Enrolling by invitation A Trial of Endostar in Combination With Chemotherapy of DF and Sequential Intensity Modulated Radiation Therapy for Patients With Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Neoplasms
Interventions: Drug: endostar;   Radiation: intensity modulated radiation;   Drug: cisplatin
30 Recruiting EpCAM CAR-T for Treatment of Nasopharyngeal Carcinoma and Breast Cancer
Conditions: Malignant Neoplasm of Nasopharynx TNM Staging Distant Metastasis (M);   Breast Cancer Recurrent
Intervention: Biological: CAR-T cells recognizing EpCAM
31 Recruiting Hyperfractionated Intensity-modulated Radiotherapy (IMRT) Versus Conventional Fraction IMRT for Patients With Loco-regionally Recurrent Nasopharyngeal Carcinoma.
Conditions: Nasopharyngeal Neoplasms;   Mortality;   Quality of Life;   Complications
Interventions: Radiation: Hyperfractionated IMRT;   Radiation: Conventional Fraction IMRT
32 Recruiting Hemoglobin, Neutrophil to Lymphocyte Ratio and Platelet Count Improve Prognosis Prediction in Nasopharyngeal Carcinoma
Conditions: Nasopharyngeal Neoplasms;   Blood Cell Count;   Neoplasm Staging;   Prognosis
Intervention:
33 Active, not recruiting Nimotuzumab in Combination With Chemoradiation for Nasopharyngeal Cancer
Condition: Nasopharyngeal Cancer
Interventions: Drug: Nimotuzumab;   Drug: placebo plus chemoradiotherapy
34 Completed Parotid-sparing IMRT for Nasopharyngeal Cancer
Conditions: Nasopharyngeal Cancers;   Intensity Modulated Radiotherapy With Chemotherapy
Intervention: Radiation: Intensity modulated radiotherapy with chemotherapy
35 Not yet recruiting The Role of Adding Concurrent Chemotherapy to IMRT in the Treatment of Stage II Nasopharyngeal Carcinoma
Condition: Effects of Chemotherapy
Interventions: Drug: Concurrent chemotherapy with cisplatin;   Radiation: Intensity modulated radiotherapy
36 Active, not recruiting Family Study of Head and Neck Cancers in Taiwan
Conditions: Nasopharyngeal Neoplasms;   Herpesvirus 4, Human
Intervention:
37 Terminated Induction Chemotherapy and Chemoradiotherapy in Nasopharyngeal Cancers
Condition: Nasopharyngeal Cancers
Intervention: Procedure: Induction chemotherapy + concurrent radiochemotherapy vs. concurrent radiochemotherapy
38 Completed A Study of Capecitabine (Xeloda) as First-Line Chemotherapy in Participants With Metastatic Nasopharyngeal Cancer
Condition: Nasopharyngeal Cancer
Interventions: Drug: Capecitabine;   Drug: Cisplatin
39 Completed A Study of Xeloda (Capecitabine) in Combination With XELOX (Oxaliplatin) in Patients With Metastatic Nasopharyngeal Cancer.
Condition: Nasopharyngeal Cancer
Interventions: Drug: Oxaliplatin;   Drug: capecitabine [Xeloda]
40 Unknown  Weekly Docetaxel Plus Cisplatin as the First-line Therapy for Nasopharyngeal Cancer
Condition: Nasopharyngeal Cancer
Intervention: Drug: Docetaxel, Cisplatin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.